Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis

Authors

Yan Li, Cleveland State University
Zhidan Tu, Case Western Reserve University
Shiguang Qian, Cleveland State University
John J. Fung, Cleveland State University
Sanford D. Markowitz, Case Western Reserve University
Linda L. Kusner, George Washington UniversityFollow
Henry J. Kaminski, George Washington UniversityFollow
Lina Lu, Cleveland State University
Feng Lin, Cleveland State University

Document Type

Journal Article

Publication Date

9-1-2014

Journal

Journal of Immunology

Volume

Volume 193, Issue 5

Inclusive Pages

2127-2134

APA Citation

Li, Y., Tu, Z., Qian, S., Fung, J.J., Markowitz, S.D. et al. (2014). Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. Journal of Immunology, 193(5), 2127-2134.

Peer Reviewed

1